Withdrawal of azathioprine and antilymphocyte globulins in kidney transplant recipients with cytomegalovirus
Mourad, G.; Chong, G.; Pouliquen, M.; Ruiz, G.; Mandin, J.; Mion, C.
Transplantation Proceedings 16(5): 1313-1315
1984
ISSN/ISBN: 0041-1345 PMID: 6091303 Document Number: 225414
Document emailed within 1 workday
Related Documents
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Touraine, J.L.; Lefrançois, N.; Dubernard, J.M.; Garnier, J.L.; Eygonnet, J.P.; Gibelin, N.; Bétuel, H.; Traeger, J. 1987: Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation Transplantation Proceedings 19(1 Part 3): 1881
Metselaar, H.J.; Rothbarth, P.H.; Brouwer, R.M.; Wenting, G.J.; Jeekel, J.; Weimar, W. 1989: Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection Transplantation 48(2): 264-266
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196
Walker, R.G.; Jones, C.L.; Powell, H.R.; Becker, G.J.; Francis, D.M. 1993: Steroid withdrawal in paediatric renal transplant patients receiving cyclosporine and azathioprine Transplantation Proceedings 25(5): 2883-2885
Mozes, M.F.; Spigos, D.S.; Jonasson, O.; Thomas, P.A. 1979: Transcatheteric partial splenic embolization (PSE) for azathioprine intolerance in renal transplant recipients Transplantation Proceedings 11(1): 45-48
Gondo, H. 1998: Cytomegalovirus infection in transplant recipients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(1): 173-178
Francis, D.M.; Walker, R.G.; Jones, C.; Powell, H. 1994: Cessation of steroids in pediatric renal transplant recipients treated with cyclosporine, azathioprine, and prednisolone Transplantation Proceedings 26(1): 99-101
Jankowski, M.; Gut, W.; Nawrocka, E.; Gradowska, L.; Roncewicz, Z.; Rowińska, D. 1982: Cytomegalovirus antibodies in renal transplant recipients Acta Microbiologica Polonica 31(3-4): 279-285
Weller, S.; Thürmann, P.; Rietbrock, N.; Gossmann, J.; Scheuermann, E.H. 1995: HPLC analysis of azathioprine metabolites in red blood cells, plasma and urine in renal transplant recipients International Journal of Clinical Pharmacology and Therapeutics 33(12): 639-645
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Kumar, D.; Fattah, H.; Kimball, P.M.; LeCorchick, S.; McDougan, F.A.; King, A.L.; Gupta, G. 2016: Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: a Single Center Experience Clinical Transplants 32: 143-151
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Sivathasan, C.; Doraisingham, S.; Ling, A.E.; Ng, A.; Allen, D.M.; Tong, M.C. 1992: Is cytomegalovirus infection going to be a problem among heart transplant recipients in Singapore? Transplantation Proceedings 24(5): 2019-2021
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Pollard, R.B.; Merigan, T.C. 1978: Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 241-245
Keitel, E.; Bittar, A.E.; Losekann, A.; Deboni, L.; Ceretta, F.; Goldani, J.C.; Garcia, V.D. 1992: Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy Transplantation Proceedings 24(6): 2606-2608
Noel, C.; Dhondt, J.L.; Walter, M.P.; Dracon, M.; Pruvot, F.R.; Wattine, O.; Lelievre, G.; Dequiedt, P. 1987: Neopterin excretion for kidney transplant monitoring: relationship with antilymphocyte globulin treatment Transplantation Proceedings 19(1 Part 2): 1689-1690